This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Daewoong Pharmaceutical Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Min-Jae Cho: Innovator in Pharmaceutical Chemistry
Introduction
Min-Jae Cho is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on heterocyclic compounds. His research focuses on developing solutions for diseases linked to prolyl-tRNA synthetase activity abnormalities.
Latest Patents
Min-Jae Cho holds a patent for a heterocyclic compound, its preparation method, and a pharmaceutical composition comprising the same. This invention is represented by Chemical Formula 1 and is aimed at preventing or treating diseases caused by irregularities in PRS activity. The patent highlights the potential of this compound and its pharmaceutically acceptable salts in medical applications.
Career Highlights
Min-Jae Cho is currently associated with Daewoong Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies in the pharmaceutical industry.
Collaborations
Throughout his career, Min-Jae Cho has collaborated with esteemed colleagues, including Myung-gi Jung and Bong-Yong Lee. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Min-Jae Cho's contributions to pharmaceutical chemistry, particularly through his patent on heterocyclic compounds, underscore his role as a key innovator in the field. His ongoing work at Daewoong Pharmaceutical Co., Ltd. continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile